Search research articles
Contact Us
Filters
Showing results (81-90 of 181) with videos related to
Page
of 19
Sort By:
International Journal of Nuclear Medicine and Biology
|
January 1, 1984
In vivo and in vitro characteristics of the N-methyl derivative of [125I]3-quinuclidinyl 4-iodobenzilate
R E Gibson, H H Coenen, E Jagoda, et al.
Peptides
|
April 9, 1998
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors
T W Moody, J Leyton, E Unsworth, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 1, 1997
An automated radiopharmaceutical dispenser
P S Plascjak, K Kim, W Meyer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1979
Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay
R E Gibson, W J Rzeszotarski, T Komai, et al.
Life Sciences
|
March 9, 1999
Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands
D O Kiesewetter, R E Carson, E M Jagoda, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1982
The use of tritium labeled compounds to develop gamma-emitting receptor-binding radiotracers
B Francis, W C Eckelman, M P Grissom, et al.
Nuclear Medicine and Biology
|
July 13, 2004
Experiment assessment of mass effects in the rat: implications for small animal PET imaging
E M Jagoda, J J Vaquero, J Seidel, et al.
Synapse (New York, N.Y.)
|
February 20, 1999
In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridines
D O Kiesewetter, R E Carson, E M Jagoda, et al.
Nuclear Medicine and Biology
|
August 1, 1995
Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain
J Lee, C H Paik, D O Kiesewetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1975
Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate
K P Poulose, A E Watkins, R C Reba, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 181) with videos related to
Sort By:
Page
of 19
International Journal of Nuclear Medicine and Biology
|
January 1, 1984
In vivo and in vitro characteristics of the N-methyl derivative of [125I]3-quinuclidinyl 4-iodobenzilate
R E Gibson, H H Coenen, E Jagoda, et al.
Peptides
|
April 9, 1998
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors
T W Moody, J Leyton, E Unsworth, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 1, 1997
An automated radiopharmaceutical dispenser
P S Plascjak, K Kim, W Meyer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1979
Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay
R E Gibson, W J Rzeszotarski, T Komai, et al.
Life Sciences
|
March 9, 1999
Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands
D O Kiesewetter, R E Carson, E M Jagoda, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1982
The use of tritium labeled compounds to develop gamma-emitting receptor-binding radiotracers
B Francis, W C Eckelman, M P Grissom, et al.
Nuclear Medicine and Biology
|
July 13, 2004
Experiment assessment of mass effects in the rat: implications for small animal PET imaging
E M Jagoda, J J Vaquero, J Seidel, et al.
Synapse (New York, N.Y.)
|
February 20, 1999
In vivo muscarinic binding of 3-(alkylthio)-3-thiadiazolyl tetrahydropyridines
D O Kiesewetter, R E Carson, E M Jagoda, et al.
Nuclear Medicine and Biology
|
August 1, 1995
Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain
J Lee, C H Paik, D O Kiesewetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1975
Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate
K P Poulose, A E Watkins, R C Reba, et al.
Page
of 19